Johnson & Johnon’s Q1 profit beats as sales fall slightly short of estimates
Related Articles
-
Abbott beats quarterly profit estimates on strong medical device sales
Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday and raised the lower end of its annual forecast on robust sales of its medical devices, including glucose-monitoring products. Sales of Abbott's medical devices have been strengthened in recent quarters due to a resurgence in the demand for joint replacements as well as other surgeries delayed during the COVID-19 pandemic. Industry bellwether and rival Johnson & Johnson said on Tuesday it continues to expect...
-
J&J Profit Beats Estimates as Pharma Sales Edge Out Street
Johnson & Johnson's first-quarter profit beat estimates as the health giant's drug sales came in higher than Wall Street analysts expected.
-
Abbott’s (ABT) Diabetes Device Sales Drive Earnings Beat, Forecast
Abbott Laboratories raised the lower end of its annual profit forecast as strong sales in medical devices drove first-quarter earnings and revenue above expectations.